QR kód

ADALIMUMAB FOR ULCERATIVE COLITIS: RESULTS OF A BRAZILIAN MULTICENTER OBSERVATIONAL STUDY

ABSTRACT BACKGROUND: Adalimumab is a monoclonal antibody, tumor necrosis factor-alpha (TNFα) inhibitor that has efficacy for inducing and maintaining remission in moderate-to-severe ulcerative colitis. Real world studies with adalimumab in Latin American ulcerative colitis patients are scarce. OBJ...

Celý popis

Uloženo v:
Hlavní autoři: Patrícia ZACHARIAS, Aderson Omar Mourão Cintra DAMIÃO, Antonio Carlos MORAES, Fábio Vieira TEIXEIRA, Juliano Coelho LUDVIG, Rodrigo Bremer NONES, Rogerio SAAD-HOSSNE, Ligia Yukie SASSAKI, Rosemary Pereira Lino da SILVA, Luiza FACCHIN, Marcia OLANDOSKI, Paulo Gustavo KOTZE
Médium: Artigo
Jazyk:Inglês
Vydáno: Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE 2017-10-01
Edice:Arquivos de Gastroenterologia
Témata:
Proctocolite
Colite ulcerativa
Adalimumabe
Doenças inflamatórias intestinais
On-line přístup:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032017005011102&lng=en&tlng=en
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky